NM_000059.4(BRCA2):c.9874C>T (p.Pro3292Ser) AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 18, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000221927.3

Allele description [Variation Report for NM_000059.4(BRCA2):c.9874C>T (p.Pro3292Ser)]

NM_000059.4(BRCA2):c.9874C>T (p.Pro3292Ser)

Gene:

BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

13q13.1

Genomic location:

Preferred name:

NM_000059.4(BRCA2):c.9874C>T (p.Pro3292Ser)

HGVS:

NC_000013.11:g.32398387C>T
NG_012772.3:g.87908C>T
NM_000059.4:c.9874C>TMANE SELECT
NP_000050.2:p.Pro3292Ser
NP_000050.3:p.Pro3292Ser
LRG_293t1:c.9874C>T
LRG_293:g.87908C>T
LRG_293p1:p.Pro3292Ser
NC_000013.10:g.32972524C>T
NM_000059.3:c.9874C>T

Protein change:

P3292S

Links:

dbSNP: rs876660917

NCBI 1000 Genomes Browser:

rs876660917

Molecular consequence:

NM_000059.4:c.9874C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000278724	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Feb 18, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID] Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000278724

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Feb 18, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.

Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC.

Nature. 2005 Mar 31;434(7033):598-604.

PubMed [citation]

PMID:: 15800615

Details of each submission

From Ambry Genetics, SCV000278724.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

The p.P3292S variant (also known as c.9874C>T), located in coding exon 26 of the BRCA2 gene, results from a C to T substitution at nucleotide position 9874. The proline at codon 3292 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 1, 2024

ClinVar

Relating variation to medicine